主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文作者:Zhang Xi1 Ren Yuan1 Li Sijin2
单位:1山西医科大学附属肿瘤医院核医学科,太原030013;2山西医科大学附属第一医院核医学科,太原030001
英文单位:1Department of Nuclear Medicine, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan 030013 China; 2Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001 China
关键词:糖尿病;冠状动脉微血管功能障碍;发病机制;评价;治疗
英文关键词:Diabetes;Coronarymicrovasculardysfunction;Pathogenesis;Evaluation;Treatment
全球糖尿病患者心血管不良事件的发生率和死亡率逐年升高,其中一个重要的原因在于糖尿病患者大多存在冠状动脉微血管功能障碍(CMD)。糖尿病患者CMD的发病机制复杂,评价和治疗手段多样,目前国际上尚无专门针对糖尿病合并CMD的指南或共识,且缺乏大样本的临床研究来证实其预后和疗效。本文主要就近年来糖尿病合并CMD的发病机制、临床表现、评价方式及治疗方法的研究进展进行综述,为临床诊疗提供参考。
The morbidity and mortality of cardiovascular adverse events in diabetic patients worldwide are increasing year by year. One of the important reason is that most diabetic patients have coronary microvascular dysfunction(CMD). The pathogenesis of CMD in diabetic patients is complex, evaluation and treatment methods are diverse. At present, there is no international guidance or consensus for diabetes with CMD specifically, and there are lack of large-scale clinical studies to confirm its prognosis and efficacy. This article reviews the research progress and major findings in pathogenesis, clinical manifestations, evaluation and treatment methods of diabetic patients complicated with CMD in recent years. It is expected to provide reference for clinical diagnosis and treatment.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。